BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 11146619)

  • 21. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts.
    Kim H; You S; Kim IJ; Foster LK; Farris J; Ambady S; Ponce de León FA; Foster DN
    Oncogene; 2001 May; 20(21):2671-82. PubMed ID: 11420679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
    de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
    Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
    Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
    Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer.
    Cohen O; Kimchi A
    Cell Death Differ; 2001 Jan; 8(1):6-15. PubMed ID: 11313698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
    Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
    Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
    Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
    Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ; Dong YB; Yang H; McMasters KM
    Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
    Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation.
    Lee TA; Farnham PJ
    Oncogene; 2000 Apr; 19(18):2257-68. PubMed ID: 10822376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
    Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
    Pützer BM; Stiewe T; Crespo F; Esche H
    Gene Ther; 2000 Aug; 7(15):1317-25. PubMed ID: 10918503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
    Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death.
    Meyer K; Basu A; Saito K; Ray RB; Ray R
    Virology; 2005 Jun; 336(2):198-207. PubMed ID: 15892961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATM activity contributes to the tumor-suppressing functions of p14ARF.
    Li Y; Wu D; Chen B; Ingram A; He L; Liu L; Zhu D; Kapoor A; Tang D
    Oncogene; 2004 Sep; 23(44):7355-65. PubMed ID: 15258567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic HIV type 1 infection down-regulates expression of DAP kinase and p19ARF-p53 checkpoint and is associated with resistance to CD95-mediated apoptosis in HUT78 T cells.
    Kim CH; Chiplunkar S; Gupta S
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):183-9. PubMed ID: 15018706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.